Atrial cardiopathy: a mechanism of cryptogenic stroke

References

• Arboix A, Alio J. Acute cardioembolic stroke: an update. Expert Rev Cardiovasc Ther. 2011;9:367–379.
   PubMedGoogle Scholar
• Yaghi S, Elkind MS. Cryptogenic stroke: a diagnostic challenge. Neurol Clin Pract. 2014;4:386–393.
   PubMedGoogle Scholar
• Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial septal aneurysm. Stroke. 2002;33:706–711.
   PubMed Web of Science ®Google Scholar
• Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429–438.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Bernstein RA, Passman R, et al. Cryptogenic stroke: research and practice. Circ Res. 2017;120:527–540.
   PubMed Web of Science ®Google Scholar
• Arboix A, Marti-Vilalta JL. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc Dis. 2004;17(Suppl 1):58–62.
   PubMed Web of Science ®Google Scholar
• Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the atrial fibrillation follow-up investigation of rhythm management (affirm) study. Am Heart J. 2005;149:657–663.
   PubMed Web of Science ®Google Scholar
• Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (stroke prevention strategies based on atrial fibrillation information from implanted devices). Eur Heart J. 2014;35:508–516.
   PubMed Web of Science ®Google Scholar
• Swiryn S, Orlov MV, Benditt DG, et al. Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes. Circulation. 2016;134:1130–1140.
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517–584.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Dawber TR, Thomas HE Jr., et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973–977.
   PubMed Web of Science ®Google Scholar
• Lodder J, Bamford JM, Sandercock PA, et al. Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke. 1990;21:375–381.
   PubMed Web of Science ®Google Scholar
• Rizos T, Guntner J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43:2689–2694.
   PubMed Web of Science ®Google Scholar
• Bhatt A, Majid A, Razak A, et al. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke Res Treat. 2011;2011:172074.
   PubMedGoogle Scholar
• Rojo-Martinez E, Sandin-Fuentes M, Calleja-Sanz AI, et al. high performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism. Rev Neurol. 2013;57:251–257.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467–2477.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–2486.
   PubMed Web of Science ®Google Scholar
• Kamel H, Okin PM, Elkind MS, et al. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke. 2016;47:895–900.
   PubMed Web of Science ®Google Scholar
• Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129:2094–2099.
   PubMed Web of Science ®Google Scholar
• Daoud EG, Glotzer TV, Wyse DG, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of trends. Heart Rhythm. 2011;8:1416–1423.
   PubMed Web of Science ®Google Scholar
• Bellotti P, Spirito P, Lupi G, et al. Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. Am J Cardiol. 1998;81:1199–1202.
   PubMed Web of Science ®Google Scholar
• Warraich HJ, Gandhavadi M, Manning WJ. Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation. Stroke. 2014;45:1481–1484.
   PubMed Web of Science ®Google Scholar
• Henningsen KM, Olesen MS, Haunsoe S, et al. Association of rs2200733 at 4q25 with early onset of lone atrial fibrillation in young patients. Scand Cardiovasc J. 2011;45:324–326.
   PubMed Web of Science ®Google Scholar
• Gretarsdottir S, Thorleifsson G, Manolescu A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol. 2008;64:402–409.
   PubMed Web of Science ®Google Scholar
• Beigel R, Wunderlich NC, Ho SY, et al. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014;7:1251–1265.
   PubMed Web of Science ®Google Scholar
• Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: Implications for echocardiographic examination. Circulation. 1997;96:3112–3115.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Seo Y, Kawamatsu N, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging. 2014;7:337–343.
   PubMed Web of Science ®Google Scholar
• Petersen M, Roehrich A, Balzer J, et al. Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation. Europace. 2015;17:539–545.
   PubMedGoogle Scholar
• Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–538.
   PubMed Web of Science ®Google Scholar
• Lee JM, Seo J, Uhm JS, et al. Why is left atrial appendage morphology related to strokes? An analysis of the flow velocity and orifice size of the left atrial appendage. J Cardiovasc Electrophysiol. 2015;26:922–927.
   PubMed Web of Science ®Google Scholar
• Anselmino M, Scaglione M, Di Biase L, et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm. 2014;11:2–7.
   PubMed Web of Science ®Google Scholar
• Khurram IM, Dewire J, Mager M, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10:1843–1849.
   PubMed Web of Science ®Google Scholar
• Fukushima K, Fukushima N, Kato K, et al. Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2015;jev117.
   Web of Science ®Google Scholar
• Kishima H, Mine T, Ashida K, et al. Does left atrial appendage morphology influence left atrial appendage flow velocity? Circ J. 2015;79:1706–1711.
   PubMed Web of Science ®Google Scholar
• Lee JM, Shim J, Uhm JS, et al. Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation. Am J Cardiol. 2014;113:963–969.
   PubMed Web of Science ®Google Scholar
• Eranti A, Aro AL, Kerola T, et al. Prevalence and prognostic significance of abnormal p terminal force in lead v1 of the ECG in the general population. Circ Arrhythm Electrophysiol. 2014;7:1116–1121.
   PubMed Web of Science ®Google Scholar
• Neilan TG, Coelho-Filho OR, Shah RV, et al. Myocardial extracellular volume fraction from t1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging. 2013;6:672–683.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu X, Wei J. Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent. Biochem Biophys Res Commun. 2014;452:497–502.
   PubMed Web of Science ®Google Scholar
• Wu J, Xia S, Kalionis B, et al. The role of oxidative stress and inflammation in cardiovascular aging. Biomed Res Int. 2014;2014:615312.
   PubMed Web of Science ®Google Scholar
• Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230–243.
   PubMed Web of Science ®Google Scholar
• Jalife J. Mechanisms of persistent atrial fibrillation. Curr Opin Cardiol. 2014;29:20–27.
   PubMed Web of Science ®Google Scholar
• Sanders P, Morton JB, Davidson NC, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation. 2003;108:1461–1468.
   PubMed Web of Science ®Google Scholar
• Dzeshka MS, Lip GY, Snezhitskiy V, et al. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943–959.
   PubMed Web of Science ®Google Scholar
• Goldberger JJ, Arora R, Green D, et al. Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation. 2015;132:278–291.
   PubMed Web of Science ®Google Scholar
• Wozakowska-Kaplon B. Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period. Int J Cardiol. 2005;101:47–52.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, D’Agostino RB, Belanger AJ, et al. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995;92:835–841.
   PubMed Web of Science ®Google Scholar
• Di Tullio MR, Sacco RL, Sciacca RR, et al. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the northern Manhattan stroke study. Stroke. 2015;46:1488–1493.
   PubMed Web of Science ®Google Scholar
• Black IW. Spontaneous echo contrast: where there’s smoke there’s fire. Echocardiography (Mount Kisco, N.Y.). 2000;17:373–382.
   PubMed Web of Science ®Google Scholar
• Leung DY, Black IW, Cranney GB, et al. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1994;24:755–762.
   PubMed Web of Science ®Google Scholar
• Stoddard MF, Dawkins PR, Prince CR, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25:452–459.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr., Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the prevail trial. J Am Coll Cardiol. 2014;64:1–12.
   PubMed Web of Science ®Google Scholar
• Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (the stroke prevention in atrial fibrillation [SPAF-III] study). J Am Soc Echocardiogr. 1999;12:1080–1087.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Boehme AK, Hazan R, et al. Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study. J Stroke Cerebrovasc Dis. 2016;25:110–114.
   PubMed Web of Science ®Google Scholar
• Boeckh-Behrens T, Kleine JF, Zimmer C, et al. Thrombus histology suggests cardioembolic cause in cryptogenic stroke. Stroke. 2016;47:1864–1871.
   PubMed Web of Science ®Google Scholar
• Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med. 1995;332:162–173.
   PubMed Web of Science ®Google Scholar
• Orejarena LA, Vidaillet H Jr., DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31:150–157.
   PubMed Web of Science ®Google Scholar
• Hamer ME, Wilkinson WE, Clair WK, et al. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 1995;25:984–988.
   PubMed Web of Science ®Google Scholar
• Kamel H, Elkind MS, Bhave PD, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44:1550–1554.
   PubMed Web of Science ®Google Scholar
• Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the international society for computerized electrocardiology. Circulation. 2009;119:e251–261.
   PubMed Web of Science ®Google Scholar
• Tiffany Win T, Ambale Venkatesh B, Volpe GJ, et al. Associations of electrocardiographic p-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: the PRIMERI study. Heart Rhythm. 2015;12:155–162.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Prineas RJ, Case LD, et al. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the atherosclerosis risk in communities (ARIC) study. Stroke. 2009;40:1204–1211.
   PubMed Web of Science ®Google Scholar
• Kamel H, Soliman EZ, Heckbert SR, et al. P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis. Stroke. 2014;45:2786–2788.
   PubMed Web of Science ®Google Scholar
• Kamel H, O’Neal WT, Okin PM, et al. Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study. Ann Neurol. 2015;78:670–678.
   PubMed Web of Science ®Google Scholar
• Kamel H, Hunter M, Moon YP, et al. Electrocardiographic left atrial abnormality and risk of stroke: northern Manhattan study. Stroke. 2015;46:3208–3212.
   PubMed Web of Science ®Google Scholar
• Kamel H, Bartz TM, Longstreth WT Jr., et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the cardiovascular health study. Stroke. 2015;46:711–716.
   PubMed Web of Science ®Google Scholar
• Arboix A, Marti L, Dorison S, et al. Bayes syndrome and acute cardioembolic ischemic stroke. World J Clin Cases. 2017;5:93–101.
   PubMed Web of Science ®Google Scholar
• Martinez-Selles M, Masso-van Roessel A, Alvarez-Garcia J, et al. Interatrial block and atrial arrhythmias in centenarians: prevalence, associations, and clinical implications. Heart Rhythm. 2016;13:645–651.
   PubMed Web of Science ®Google Scholar
• Cheng S, Keyes MJ, Larson MG, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009;301:2571–2577.
   PubMed Web of Science ®Google Scholar
• Thijs VN, Brachmann J, Morillo CA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: results from crystal AF. Neurology. 2016;86:261–269.
   PubMed Web of Science ®Google Scholar
• Montalvo M, Tadi P, Merkler A, et al. PR interval prolongation and cryptogenic stroke: a multicenter retrospective study. J Stroke Cerebrovasc Dis. 2017 Jun 27. pii: S1052-3057(17)30268-9. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.036. [Epub ahead of print].
   Web of Science ®Google Scholar
• Yaghi S, Liberman AL, Atalay M, et al. Cardiac magnetic resonance imaging: a new tool to identify cardioaortic sources in ischaemic stroke. J Neurol Neurosurg Psychiatry. 2017;88:31–37.
   PubMed Web of Science ®Google Scholar
• Rutten JH, Mattace-Raso FU, Steyerberg EW, et al. Amino-terminal pro-b-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension. 2010;55:785–791.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Laughlin GA, Clopton P, et al. Minimally elevated cardiac troponin t and elevated n-terminal pro-b-type natriuretic peptide predict mortality in older adults: results from the rancho Bernardo study. J Am Coll Cardiol. 2008;52:450–459.
   PubMed Web of Science ®Google Scholar
• Kistorp C, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretic peptide, c-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–1616.
   PubMed Web of Science ®Google Scholar
• Cushman M, Judd SE, Howard VJ, et al. N-terminal pro-b-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke. 2014;45:1646–1650.
   PubMed Web of Science ®Google Scholar
• Saunders JT, Nambi V, de Lemos JA, et al. Cardiac troponin t measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123:1367–1376.
   PubMed Web of Science ®Google Scholar
• Dadu RT, Fornage M, Virani SS, et al. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013;44:1803–1808.
   PubMed Web of Science ®Google Scholar
• Berntsson J, Zia E, Borne Y, et al. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke. Cerebrovasc Dis. 2014;37:444–450.
   PubMed Web of Science ®Google Scholar
• Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke. 2015;46:1187–1195.
   PubMed Web of Science ®Google Scholar
• Scheitz JF, Erdur H, Haeusler KG, et al. Insular cortex lesions, cardiac troponin, and detection of previously unknown atrial fibrillation in acute ischemic stroke: insights from the troponin elevation in acute ischemic stroke study. Stroke. 2015;46:1196–1201.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Yanez M, Arias-Rivas S, Santamaria-Cadavid M, et al. High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke. Neurology. 2013;81:444–447.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. Association of troponin t detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503–2512.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Nambi V, Bell EJ, et al. Troponin t, n-terminal pro-b-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013;44:961–967.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Xu H, Stamova B, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol. 2010;68:681–692.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Boehme AK, Hazan R, et al. Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study. J Stroke Cerebrovasc Dis. 2016;25:110–114.
   PubMed Web of Science ®Google Scholar
• Sebasigari D, Merkler A, Guo Y, et al. Biomarkers of atrial cardiopathy and atrial fibrillation detection on mobile outpatient continuous telemetry after embolic stroke of undetermined source. J Stroke Cerebrovasc Dis. 2017;26:1249–1253.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288:2441–2448.
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–962.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364:806–817.
   PubMed Web of Science ®Google Scholar
• Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859–1869.
   PubMed Web of Science ®Google Scholar
• Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635–641.
   PubMed Web of Science ®Google Scholar
• Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004–1009.
   PubMed Web of Science ®Google Scholar
• Longstreth WT Jr., Kronmal RA, Thompson JL, et al. Amino terminal pro-b-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke. 2013;44:714–719.
   PubMed Web of Science ®Google Scholar